4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001193125-25-226846
Director acquired 1,740,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moin Andrew Director | 2025-09-29 | Option exercise | +1,740,000 | $1.75 | $3,045,000 | 2,198,457 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Moin Andrew Director | 2025-09-29 | Option exercise · Series B Convertible Preferred Stock | −17,400 | 211,100 | I: show line 2 in the form |
Loading xslF345X05/ownership.xml…